%0 Journal Article
%@ 2561-326X
%I JMIR Publications
%V 3
%N 4
%P e13286
%T Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis
%A Chen,Jessica
%A Kaye,Leanne
%A Tuffli,Michael
%A Barrett,Meredith A
%A Jones-Ford,Shelanda
%A Shenouda,Tina
%A Gondalia,Rahul
%A Henderson,Kelly
%A Combs,Veronica
%A Van Sickle,David
%A Stempel,David A
%+ Propeller Health, 47 Maiden Lane, 3rd Floor, San Francisco, CA, United States, 1 608 251 0470, leanne.kaye@propellerhealth.com
%K chronic obstructive pulmonary disease
%K telemedicine
%K quality improvement, feasibility
%K nebulizers and vaporizers
%K health services
%D 2019
%7 23.10.2019
%9 Original Paper
%J JMIR Form Res
%G English
%X Background: Digital health programs assist patients with chronic obstructive pulmonary disease (COPD) to better manage their disease. Technological and adoption barriers have been perceived as a limitation. Objective: The aim of the research was to evaluate a digital quality improvement pilot in Medicare-eligible patients with COPD. Methods: COPD patients were enrolled in a digital platform to help manage their medications and symptoms as part of their routine clinical care. Patients were provided with electronic medication monitors (EMMs) to monitor short-acting beta-agonist (SABA) use passively and a smartphone app to track use trends and receive feedback. Providers also had access to data collected via a secure website and were sent email notifications if a patient had a significant change in their prescribed inhaler use. Providers then determined if follow-up was needed. Change in SABA use and feasibility outcomes were evaluated at 3, 6, and 12 months. Results: A total of 190 patients enrolled in the pilot. At 3, 6, and 12 months, patients recorded significant reductions in daily and nighttime SABA use and increases in SABA-free days (all P<.001). Patient engagement, as measured by the ratio of daily active use to monthly active use, was >90% at both 6 and 12 months. Retention at 6 months was 81% (154/190). Providers were sent on average two email notifications per patient during the 12-month program. Conclusions: A digital health program integrated as part of standard clinical practice was feasible and had low provider burden. The pilot demonstrated significant reduction in SABA use and increased SABA-free days among Medicare-eligible COPD patients. Further, patients readily adopted the digital platform and demonstrated strong engagement and retention rates at 6 and 12 months. 
%M 31647471
%R 10.2196/13286
%U http://formative.jmir.org/2019/4/e13286/
%U https://doi.org/10.2196/13286
%U http://www.ncbi.nlm.nih.gov/pubmed/31647471